Registry and biobank for adults with pulmonary hypertension
Prospective Registry and Biobank for Long-term Observational Studies in Adult Patients with Pulmonary Hypertension
This study is collecting health information and samples from adults with pulmonary hypertension to learn more about the condition and how different treatments work over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 5000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Universitätsklinikum Hamburg-Eppendorf Academic / other |
| Locations | 1 site (Hamburg, Free and Hanseatic City of Hamburg) |
| Trial ID | NCT04654650 on ClinicalTrials.gov |
What this trial studies
This study involves creating a prospective registry and biobank for adult patients diagnosed with various groups of pulmonary hypertension. Participants will be enrolled and their body fluid samples will be collected at the start and during treatment with targeted therapies. The aim is to gather long-term observational data to better understand the condition and its treatment outcomes.
Who should consider this trial
Good fit: Ideal candidates are adults diagnosed with pulmonary hypertension classified in groups 1 to 5.
Not a fit: Patients who are unable to provide informed consent or choose to withdraw consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of pulmonary hypertension and improve treatment strategies for patients.
How similar studies have performed: Other studies involving registries and biobanks for chronic conditions have shown success in improving patient outcomes and understanding disease progression.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of pulmonary hypertension group 1 to 5 * Ability to give informed consent Exclusion Criteria: \- Withdrawal of informed consent
Where this trial is running
Hamburg, Free and Hanseatic City of Hamburg
- Universitätsklinikum Hamburg-Eppendorf — Hamburg, Free and Hanseatic City of Hamburg, Germany (Recruiting)
Study contacts
- Study coordinator: Lars Harbaum, MD
- Email: l.harbaum@uke.de
- Phone: +4940741018337
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.